Methotrexate in Combination With Infliximab Is No More Effective Than Infliximab Alone in Patients With Crohn's Disease
- 1 March 2014
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 146 (3) , 681-688.e1
Abstract
No abstract availableKeywords
Funding Information
- Crohn's and Colitis Foundation of America
- Merck
This publication has 30 references indexed in Scilit:
- Infliximab, Azathioprine, or Combination Therapy for Crohn's DiseaseNew England Journal of Medicine, 2010
- Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM TrialGastroenterology, 2007
- Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s DiseaseClinical Gastroenterology and Hepatology, 2006
- Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT RegistryClinical Gastroenterology and Hepatology, 2006
- Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled TrialGastroenterology, 2006
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- A controlled double blind study of azathioprine in the management of Crohn??s diseaseEuropean Journal of Gastroenterology & Hepatology, 1995
- A controlled double blind study of azathioprine in the management of Crohn's disease.Gut, 1995
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980